Search

everythinglearnresearchcommunity

for

Search:↓

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

The document concludes that scalp conditions have various causes and can present in many different ways.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

A specific ATR gene mutation is linked to a hereditary oropharyngeal cancer syndrome.

Wnt signaling is crucial for skin, hair, and nail health and regeneration.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Nanotechnology is improving skin treatments and cosmetics.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Patients with chronic kidney disease often have various skin problems that affect their quality of life, but early treatment can help.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Nail disorders are often related to jobs like housework and manual labor, with cosmetic issues being the main concern, and are commonly caused by skin diseases like psoriasis.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New cancer drugs often cause skin and nail problems.